Evidence map›Paper›PMID 37575238›Full record

ArticleFrontiers in immunology2023

IL-12/15/18-induced cell death and mitochondrial dynamics of human NK cells.

Iñigo Terrén, Víctor Sandá, Ainhoa Amarilla-Irusta, Ainara Lopez-Pardo, Arrate Sevilla, Gabirel Astarloa-Pando, Laura Amo, Olatz Zenarruzabeitia, Luca Scorrano, Francisco Borrego

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. IL-18-Mediated Tumor Immune Evasion.Current issues in molecular biology · 2026
    Review
  3. Article
  4. Review
  5. Observational
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. NK cells in HPV-related tumorigenesis: mechanisms and clinical applications.Frontiers in cellular and infection microbiology · 2025
    Review
  12. Review
  13. Review
  14. Article
  15. Article
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Iñigo TerrénImmunopathology Group, Biocruces Bizkaia Health Research Institute, Barakaldo, Spain.
Víctor SandáImmunopathology Group, Biocruces Bizkaia Health Research Institute, Barakaldo, Spain.
Ainhoa Amarilla-IrustaImmunopathology Group, Biocruces Bizkaia Health Research Institute, Barakaldo, Spain.
Ainara Lopez-PardoImmunopathology Group, Biocruces Bizkaia Health Research Institute, Barakaldo, Spain.
Arrate SevillaImmunopathology Group, Biocruces Bizkaia Health Research Institute, Barakaldo, Spain.
Gabirel Astarloa-PandoImmunopathology Group, Biocruces Bizkaia Health Research Institute, Barakaldo, Spain.
Laura AmoImmunopathology Group, Biocruces Bizkaia Health Research Institute, Barakaldo, Spain.
Olatz ZenarruzabeitiaImmunopathology Group, Biocruces Bizkaia Health Research Institute, Barakaldo, Spain.
Luca ScorranoDepartment of Biology, University of Padova, Padova, Italy.
Francisco BorregoImmunopathology Group, Biocruces Bizkaia Health Research Institute, Barakaldo, Spain.
BioCruces Health research Institute · ESIkerbasque · ESVeneto Institute of Molecular Medicine · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Natural killer (NK) cells are lymphocytes with potent antitumor functions and, consequently, several NK cell-based strategies have been developed for cancer immunotherapy. A remarkable therapeutic approach is the adoptive transfer of NK cells stimulated with IL-12, IL-15 and IL-18. This cytokine stimulation endows NK cells with properties that resemble immunological memory and, for this reason, they are known as cytokine-induced memory-like (CIML) NK cells. Very promising results have been reported in clinical trials and yet, there are still unknown aspects of CIML NK cells. Here, we have conducted a preliminary study of their mitochondrial dynamics. Our results show that upon IL-12/15/18 stimulation the viability of NK cells decreased and an increment in mitochondrial superoxide levels was observed. In addition, we found that mitochondria appeared slightly elongated and their cristae density decreased following IL-12/15/18 stimulation, possibly in a process mediated by the low levels of optic atrophy type 1 (OPA1) protein. Interestingly, although mitophagy was slightly impaired, an increase in autophagic flux was observed, which might explain the reduced viability and the accumulation of unfit mitochondria. Our findings could be of relevance in order to design new strategies intended to improve the mitochondrial fitness of IL-12/15/18-stimulated NK cells with the aim of improving their therapeutic efficacy.

Indexed as

Interleukin-18Mitochondrial DynamicsCytokinesHumansInterleukin-12Killer Cells, NaturalCytokinesInterleukin-12Interleukin-18cancer immunotherapycytokine-preactivated NK cellsIL-12IL-15IL-18memory-likemitochondriaNK cells

Identifiers

PMID37575238
PMCPMC10413107
OpenAlexW4385363582

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.